Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/040774
CTRI/2022/03/040774
Completed
Phase 2

preclinical and clinical evaluation of the effect on oral administration of POONAI MEESAI CHOORANAM KUDINEER in the management of OOTHU SOBAI

Dr P Narmatha0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes
Sponsor
Dr P Narmatha
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 17, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr P Narmatha

Eligibility Criteria

Inclusion Criteria

  • •Oedema due to renal impairment

Exclusion Criteria

  • •Children above 12 years
  • •Children below 3 years
  • •Hypothyroidism
  • •Cushing syndrome
  • •Oedema due to drug allergy
  • •Oedema mimics obesity in children
  • •Acute glomerular nephritis
  • •Chronic glomerular nephritis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
preclinical and clinical evaluation of the effect of siddha classical drug KANAI KIRUTHAM(oral administration)in the management of WHEEZING ASSOCIATED LOWER RESPIRATORY TRACT INFECTIOHealth Condition 1: J459- Other and unspecified asthma
CTRI/2022/02/039924Dr J Jayamani40
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreHealth Condition 1: G819- Hemiplegia, unspecified
CTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childre
CTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecified
CTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsy
CTRI/2022/06/043082Dr P RAJAVATHANA40